CC
FLGT icon

Centiva Capital’s Fulgent Genetics FLGT Stock Holding History

Centiva Capital’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-17,410
Closed -$322K – 1736
2024
Q4 		$322K Buy
17,410
+4,872
+39% +$95.1K 0.01% 1088
2024
Q3 		$272K Buy
12,538
+1,774
+16% +$39.7K 0.01% 1638
2024
Q2 		$211K Buy
+10,764
New +$225K ﹤0.01% 1662
2023
Q4 		– Sell
-8,002
Closed -$214K – 1939
2023
Q3 		$214K Buy
+8,002
New +$273K ﹤0.01% 1354
2021
Q2 		– Sell
-2,796
Closed -$270K – 1455
2021
Q1 		$270K Buy
+2,796
New +$289K 0.01% 841

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.47B AUM 86.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Centiva Capital's FLGT Position: Q1 2025 in Review

Centiva Capital sold out of Fulgent Genetics (FLGT) in Q1 2025, closing a stake of 17,410 shares — an estimated $322K sold.

Centiva Capital first reported a position in FLGT in Q1 2021 and held it in 5 quarters. The position peaked at $322K in Q4 2024. 176 funds tracked by Wall St. Rank hold FLGT as of Q1 2025.

  • Centiva Capital reported no remaining Fulgent Genetics position as of Q1 2025 after selling out during the quarter.
  • Centiva Capital sold 17,410 Fulgent Genetics shares in Q1 2025, an estimated $322K.
  • Centiva Capital first reported a position in Fulgent Genetics in Q1 2021 and held it in 5 quarters.
  • Centiva Capital's Fulgent Genetics position peaked at $322K in Q4 2024.
  • 176 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2025.

Based on Centiva Capital's 13F filing for Q1 2025, filed 15 May 2025.